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The dimeric 14-3-3 proteins dock onto pairs of phosphorylated Ser and Thr residues on hundreds of proteins, and thereby
regulate many events in mammalian cells. To facilitate global analyses of these interactions, we developed a web resource
named ANIA: ANnotation and Integrated Analysis of the 14-3-3 interactome, which integrates multiple data sets on 14-3-3-
binding phosphoproteins. ANIA also pinpoints candidate 14-3-3-binding phosphosites using predictor algorithms, assisted
by our recent discovery that the human 14-3-3-interactome is highly enriched in 2R-ohnologues. 2R-ohnologues are pro-
teins in families of two to four, generated by two rounds of whole genome duplication at the origin of the vertebrate
animals. ANIA identifies candidate ‘lynchpins’, which are 14-3-3-binding phosphosites that are conserved across members of
a given 2R-ohnologue protein family. Other features of ANIA include a link to the catalogue of somatic mutations in cancer
database to find cancer polymorphisms that map to 14-3-3-binding phosphosites, which would be expected to interfere
with 14-3-3 interactions. We used ANIA to map known and candidate 14-3-3-binding enzymes within the 2R-ohnologue
complement of the human kinome. Our projections indicate that 14-3-3s dock onto many more human kinases than has
been realized. Guided by ANIA, PAK4, 6 and 7 (p21-activated kinases 4, 6 and 7) were experimentally validated as a 2R-
ohnologue family of 14-3-3-binding phosphoproteins. PAK4 binding to 14-3-3 is stimulated by phorbol ester, and involves
the ‘lynchpin’ site phosphoSer99 and a major contribution from Ser181. In contrast, PAK6 and PAK7 display strong phorbol
ester-independent binding to 14-3-3, with Ser113 critical for the interaction with PAK6. These data point to differential 14-
3-3 regulation of PAKs in control of cell morphology.
Database URL: https://ania-1433.lifesci.dundee.ac.uk/prediction/webserver/index.py
.............................................................................................................................................................................................................................................................................................
Introduction
The eukaryotic 14-3-3 family of phosphoprotein-binding
proteins exert pleiotropic regulatory effects by docking
onto a constellation of intracellular targets. Collating the
cumulative data from low- (LT) and high-throughput (HT)
studies of 14-3-3-binding phosphoproteins has given valu-
able insights into 14-3-3 specificities, and how 14-3-3s regu-
late cellular responses to growth factors and other stimuli
(1–3). Identifying patterns in the global data also led to
exciting discoveries about how the 14-3-3-interactome
was shaped by major evolutionary changes in the verte-
brate animals, and highlighted that 14-3-3s interact
with many proteins that are deregulated in cancer, and
metabolic and neurological disorders (1,4). To facilitate
further discoveries, here we developed ANIA, a web
resource for ANnotation and Integrated Analysis of the
14-3-3 interactome.
The 14-3-3s are dimers in which two curved L-shaped
monomers form a boat shape around an 35 A˚ wide
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inner groove that has a phosphoSer/Thr-binding pocket at
either side. 14-3-3 dimers therefore dock onto pairs of
phosphosites, and these are usually in tandem on the
same target. The paired sites sometimes lie close to or
either side of a domain or motif in the target, which is
occluded by the bound 14-3-3. In other cases, the two phos-
phosites lie within a disordered region where the 14-3-3
can impose a conformational change on the target (5–8).
The binding specificity of 14-3-3s is determined by overall
steric fit and by the linear sequence around the phosphory-
lated binding sites. Screens of synthetic phosphopeptides
showed that mode I RSX(pS)XP and mode II RX(F/Y)
X(pS)XP sequences display optimal binding to 14-3-3s
(8,9). These data were used as the basis of the 14-3-3-
phosphosite prediction algorithm within Scansite (9).
When >200 experimentally determined 14-3-3-binding
sites [dubbed ‘gold standards’ (GDs)] were analysed, vari-
ants on the mode I RSX(pS/pT)XP motifs were found to
dominate, although the +2 proline residue occurs in less
than half (5) including the mode III sites where the 14-3-
3-binding phosphosite is the penultimate C-terminal resi-
due. Around half of the sites also had a phosphorylatable
serine at residue 2 relative to the phosphosite that binds
to the 14-3-3 (1,10). While the protein kinases responsible
for creating 14-3-3-binding phosphosites are known for
only a limited number of cases, 14-3-3-binding sequences
generally conform to the types of motifs generated by dif-
ferent basophilic protein kinase A/protein kinase G/protein
kinase C family (AGC) and Ca2+/calmodulin-dependent pro-
tein kinase (CaMK) protein kinases (5,11). Consistent with
these observations, 14-3-3-phosphoprotein interactions me-
diate cellular responses to insulin, growth factors and other
stimuli that activate these kinases (12–14).
Remarkably, the GD human 14-3-3-binding phosphopro-
teins were recently discovered to be highly enriched in
2R-ohnologues. 2R-ohnologues are members of families
of two to four proteins that were generated by two
rounds of whole genome duplication (2R-WGD) at the ori-
gins of the vertebrate animals during the Cambrian period
(15). While most of the quadruplicated DNA reverted to the
singleton state, the retained 2R-WGD protein-coding gene
families are highly enriched in signaling proteins in general
(16), and 14-3-3-binding phosphoproteins in particular (1).
Human 2R-ohnologue families were identified whose
members share one conserved ‘lynchpin’ 14-3-3-binding
phosphosite. Lynchpins also align with a Ser/Thr residue in
the single pro-orthologue proteins of the invertebrate
chordates, namely Branchiostoma (Cephalochordata) and
Ciona (tunicates), which are proxy for the pre-2R-WGD an-
cestor. In contrast, the second 14-3-3-binding sites may
differ in different family members (1). These phosphoryl-
ation patterns inspired the hypothesis that 14-3-3 dimers
may have helped shape the evolutionary divergence of
their target 2R-ohnologue families. It is proposed that
binding of 14-3-3s to conserved lynchpin phosphosites pro-
vided sufficient regulation that secondary sites in different
family members were freer to evolve into sites that are
phosphorylated by different kinases and exhibit different
affinities for 14-3-3s. The resulting 2R-ohnologue families
therefore operate as ‘signal multiplexing’ systems that in-
tegrate more regulatory inputs than the single ancestral
protein, providing the increased signaling complexity
needed for vertebrate life (1,16,17). To test the lynchpin
and signal multiplexing hypotheses further and explore
their biomedical implications, there is a pressing need to
map the 14-3-3-interactome and 14-3-3-binding phospho-
sites systematically.
As well as the GD 14-3-3-binding phosphoproteins, a
growing number of proteins have been isolated in HT
14-3-3-affinity capture experiments, and identified by
mass spectrometric methods (2,12–14). These proteins
likely include phosphoproteins that bind directly to 14-3-
3s, proteins that bind indirectly to 14-3-3s as components
of multi-subunit complexes and proteins that have been
isolated non-specifically (though the HT experiments
use strategies to enhance specificity). Given the striking en-
richment of 2R-ohnologues among the GD 14-3-3-binding
phosphoproteins (1), we surmise that 2R-ohnologues would
make a useful priority list for validation of targets identi-
fied in HT experiments. Using 2R-ohnologue sequence
alignments and bioinformatics methods to search for po-
tential ‘lynchpins’ and second sites should also accelerate
efforts to pinpoint regulatory 14-3-3-binding sites.
Here, we therefore generated ANIA, which integrates
GD and HT data sets of 14-3-3-binding phosphoproteins,
sorts the proteins into 2R-ohnologue families and uses a
prediction algorithm based on the GD 14-3-3-binding phos-
phosites (unpublished work by Michele Tinti and the group
of Geoff Barton) as well as sequence conservation analysis
to search for potential lynchpin 14-3-3-binding phospho-
sites. The human protein kinome was used as a ‘test data
set’ for analysis by ANIA. Protein kinases work with 14-3-3s
in two ways: certain protein kinases create 14-3-3-binding
phosphosites, and protein kinases that bind to 14-3-3s have
also been identified. From ANIA we retrieved the list of
2R-ohnologue protein kinase families. Known and candi-
date 14-3-3-binding kinases were identified in every
subfamily of the human kinome, and potential 14-3-3-
binding lynchpin phosphorylated sites were identified.
These bioinformatics predictions led to the p21-activated
kinases (PAK)4/6/7 protein kinases being experimentally
validated as a 14-3-3-binding 2R-ohnologue family.
Materials and Methods
The list of ‘GD’ mammalian proteins for which 14-3-3-
binding sites have been reported (1) was updated by
searching PubMed up to October 2013. For a protein to
.............................................................................................................................................................................................................................................................................................
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be assigned as a GD, 14-3-3-binding phosphosites had to be
shown to be phosphorylated in vivo using 32P labelling,
phospho-specific antibodies and/or mass spectrometry and
annotated as phosphorylated in PhosphoSitePlus (18),
Phospho.ELM (19) or UniProt (20), and 14-3-3 binding had
to be eliminated by dephosphorylation and/or mutagenesis
of the candidate sites. Some studies also demonstrated
functional correlation between phosphorylation and 14-3-
3 binding in vivo and in vitro, and structural analysis of the
target–14-3-3 interaction. A list of ‘silver standards’ was
also prepared from the literature, meaning proteins
demonstrated to display direct phosphorylation-dependent
binding to 14-3-3s, but where phosphorylated residues
were not identified. Relevant references are cited in elec-
tronic supplementary material (Supplementary Table S1).
Each 14-3-3 binding protein was mapped to the human
UniProt entry (6 March 2013 release) (20) to be stored in
the database.
The list of HT experiments reported in (5) was updated
by searching PubMed up to October 2013. The identified
proteins were mapped to the human UniProt entry
(6 March 2013 release) (20) to be stored in the database.
The GD data set and HT data sets can be downloaded from
ANIA (https://ania-1433.lifesci.dundee.ac.uk/prediction/web
server/index.py/download). Proteins found to bind non-
specifically to Sepharose or agarose beads in control experi-
ments in our laboratory (2) are labeled as ‘contaminants’ in
the database, though this does not exclude the possibility
that these proteins may also display specific binding to
14-3-3.
The data set of 2R-ohnologue protein families was as
described in (1), drawing on data in (21,22). Additionally,
the 2R-ohnologue complement of the human protein
kinome was manually compiled by performing phylogen-
etic and gene synteny analyses of 2R-ohnologue families as
in (1) (Supplementary Table S2). The Branchiostoma and
Ciona pro-orthologues corresponding to each human
2R-ohnologue protein kinase family were also identified
using an automated python script with BLAST over the
non-redundant protein sequence database at NCBI (http://
blast.ncbi.nlm.nih.gov/Blast.cgi), followed by manual
inspection.
To identify candidate lynchpin 14-3-3-binding phospho-
sites, we first aligned members of each human protein
2R-ohnologue family, together with the corresponding
Branchiostoma and Ciona pro-orthologue of that family.
The alignments were performed with five different mul-
tiple sequence alignment programs [ClustalO (23),
ClustalW2 (24), Mafft (25), Muscle (26) and T-coffee (27)].
This was achieved by compiling a python script to interface
with the Representational state transfer web service at the
EBI. A python script with Biopython library (28) was used to
identify conserved serine and threonine residues in the
alignments. Thereafter, candidate 14-3-3-binding serine
and threonine residues in the human protein were selected
using a prediction algorithm developed in our laboratory
(Michele Tinti and the group of Geoff J. Barton, in prepar-
ation), by using the GD 14-3-3-binding phosphosites to train
a Position-Specific Scoring Matrix and a Neural Network.
Predicted sites from both methods were labeled ‘candidate
lynchpin’ if the sites are conserved in the human proteins
from a given 2R-ohnologue family and also in the
Branchiostoma or Ciona pro-orthologue proteins, and are
annotated as phosphorylated in PhosphoSitePlus (18),
Phospho.ELM (19) or UniProt (20). We excluded regions
annotated in UniProt as ‘extracellular’ and ‘transmem-
brane’ from these analyses.
Rat and mouse orthologues for the human proteins were
also retrieved from InParanoid (29), and by using auto-
mated BLAST (80% threshold homology applied).
Additionally, single nucleotide polymorphisms that map
to known and predicted 14-3-3-binding phosphosites were
retrieved from the catalogue of somatic mutations in
cancer (COSMIC) database (www.sanger.ac.uk/genetics/
CGP/cosmic/) (30), ontology keywords were retrieved from
UniProt (20), and proteins were linked with diseases using
the Genetic Association Database (31).
Pre-computed predictions were generated for all human
2R-ohnologue proteins. Results are visualized using
embedded Jalview applets (32) to show features of the
candidate lynchpins, including sequence conservation, se-
quence disorder using GlobPlot predictions (33) and
where they exist, GD experimentally determined 14-3-3-
binding phosphosites are highlighted.
DAVID analysis
We queried ANIA with the UniProt identifiers (Ids) from the
6 March 2013 release, downloaded the results from the
ANIA database and submitted the GD proteins plus
2R-ohnologue proteins containing candidate lynchpins to
the DAVID Database for functional annotation clustering
with high stringency. We similarly analysed a second list
of UniProt Ids from which kinases were filtered out.
Biochemical analyses
PAK4, PAK6 and PAK7 cDNAs (coding for Genbank se-
quences O96013, Q9NQU5 and Q9P286, respectively) were
amplified from IMAGE consortium EST clones 3 867 403,
5 170 347 and 4821164, respectively. The vector for expres-
sion of proteins in HEK293 cells was pcDNA5 FRT/TO that
adds a C-terminal GFP tag to the expressed protein. PAK4
cDNA was cloned into this plasmid as a BamHI/NotI insert at
the multiple cloning site just upstream of, and in frame
with, the GFP coding sequence. PAK6 and PAK7 cDNAs
were cloned into the same vector as EcoRI/NotI inserts.
Polymerase chain reaction and mutagenesis reactions
were carried out using KOD Hot Start DNA polymerase
(Novagen), and DNA sequencing was performed by The
.............................................................................................................................................................................................................................................................................................
Page 3 of 15
Database, Vol. 2014, Article ID bat085, doi:10.1093/database/bat085 Original article
.............................................................................................................................................................................................................................................................................................
 at U
niversity of D
undee on D
ecem
ber 23, 2015
http://database.oxfordjournals.org/
D
ow
nloaded from
 
Sequencing Service, College of Life Sciences, University of
Dundee.
For biochemical analyses of the PAK protein kinases,
HEK293 cells cultured in medium containing 10% (v/v)
fetal bovine serum were transfected to express the indi-
cated GFP-tagged proteins. Where indicated, after 24h,
cells were serum-starved for 10h, then stimulated with,
phorbol-12-myristate-13-acetate (PMA, 100nM for
30min). PAK-GFP proteins were isolated from cell lysates
(2.5mg) using GFP-Trap agarose (Chromotek), and
washed thrice with lysis buffer [40 mM Tris–HCl (pH 7.5),
1mM EDTA, 1mM EGTA, 1% (v/v) Triton X-100, 1mM
sodium orthovanadate, 10mM sodium b-glycerophosphate,
50mM sodium fluoride, 5mM sodium pyrophosphate,
0.27M sucrose, 1 mM microcystin-LR, 0.1% 2-mercaptoetha-
nol, 1mM benzamidine, 0.2mM PMSF and one ‘Complete’
protease inhibitor cocktail tablet (Roche) per 50 ml]. The
isolated proteins were tested for their ability to interact
directly with 14-3-3 in Far-Western assays, in which
digoxygenin-labelled 14-3-3 (a mix of the Saccharomyces
cerevisiae BMH1 and BMH2 14-3-3 isoforms) take the
place of the primary antibody that would be used in a con-
ventional western blot (12). 14-3-3 proteins from the
HEK293 cell lysate that co-immunoprecipitated with the
PAK-GFP proteins were detected with the pan-14-3-3 anti-
body K19 (Santa Cruz).
For dephosphorylation reactions, GFP-Trap beads (5 ml,
bulked out with 45 ml of Sepharose) were used to isolate
GFP-tagged proteins from 2mg of lysate of transfected
HEK293 cells. The beads were washed into reaction buffer
[50mM Tris–HCl, pH 7.5, 100mM NaCl, 0.1mM EGTA,
0.01% Brij-35 and 2mM dithiothreitol (DTT)] and split for
three 50-ml reactions. Proteins were dephosphorylated with
3mg of lambda phosphatase in the presence of 2mM
MnCl2, plus 10mM EDTA for the inhibited control, for
30min at 308C. After further washing, beads were resus-
pended in sodium dodecyl sulphate sample buffer and ana-
lysed for retention of copurified endogenous 14-3-3
proteins (K19 pan-14-3-3 antibody), and for the ability of
proteins to bind directly to 14-3-3s in Far-Western overlays.
Results
The database part of ANIA provides a simple user interface
to retrieve information on proteins that have been identi-
fied in HT and LT experiments, and 14-3-3-binding phos-
phosites that have been defined experimentally. Users can
search using UniProt identifiers of any human, mouse or rat
protein (Figure 1A). Such a search returns a tabular over-
view of information on the query protein and other mem-
bers of its 2R-ohnologue family (when relevant), indicating
which of these proteins are gold-standard 14-3-3 binders,
which exist in data sets of HT 14-3-3 experiments, and a link
to pre-computed predictions of candidate 14-3-3-binding
sites when available (Figure 1B). From the results overview
page, one can link to a ‘Candidate sites’ webpage contain-
ing Jalview applets, which enable a richer analysis of the
sequence alignments and candidate lynchpin phosphosites
(see later example of the PAK kinases). When available, a
number in parenthesis to the right of the candidate lynch-
pin indicates the position of a predicted secondary site that
resides after 19 and no more than 40 amino acids from the
lynchpin, and which may help to identify the second of a
pair of 14-3-3-binding phosphosites on a target (Figure 2):
While tandem pairs of phosphosites can bind to the same
14-3-3 dimer if they are a minimum of 15 residues apart,
with no maximum, 20–40 residues is a typical gap between
two sites within a disordered region (5). Additional meta-
data are shown from the ‘Detailed’ link, including informa-
tion of somatic cancer mutations that map to known and
candidate 14-3-3-binding phosphosites, information on
whether proteins appear in a data set of typical contamin-
ants in HT experiments [from in-house data, as reported
in (1)], and links to data on gene-associated diseases
(Figure 3). Additionally, enriched information from
UniProt and gene ontology (GO) is provided as well as
any cancer polymorphisms annotated in COSMIC. The ra-
tionale for providing the cancer polymorphisms informa-
tion comes from the observation that several 14-3-3
binding regions contain polymorphisms that could in prin-
ciple interfere with the binding to 14-3-3 (Supplementary
Figure S1). In some cases, polymorphisms that disrupt 14-3-3
interactions have been linked in a causative way to disease,
and identifying further cases therefore has implications for
the discovery of new disease biomarkers and for the devel-
opment of molecular tools that interfere with 14-3-3-
phosphoprotein interactions (34,35). All the queried data
can be downloaded from the website as tab-formatted
flat files.
Alternatively, a ‘Protein List’ query can be used by sub-
mitting a list of human/mouse/rat UniProt identifiers
(Figure 1A). Such a search could be used, for example,
to compare the results of a new HT experiment with the
existing data. In the results page, the protein list queries
assemble the result for each submitted protein in a differ-
ent line (as outlined above for individual protein queries)
(Figure 1B).
Use of ANIA to browse the data from high-thoughput
(HT) 14-3-3-affinity capture experiments
To date, ANIA contains information from 23 HT experi-
ments in which proteins were captured on immobilized
14-3-3 from extracts of mammalian cells and tissues
(https://ania-1433.lifesci.dundee.ac.uk/prediction/webser-
ver/index.py/download). The representation of GDs in these
HT data sets is relatively low (3%), which means that much
work is needed to distinguish which of the protein hits
from the HT experiments are phosphoproteins that bind
.............................................................................................................................................................................................................................................................................................
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Figure 1. Protein query on ANIA. (A) Homepage of ANIA showing the protein and protein list query fields. (B) Sample results
webpage for the default protein list query. The result page display the UniProt Id (UniProt), the UniProt name (Name) and the
presence of a Golden Standard site (GD) on the query proteins. The page also lists the mapping of the input UniProt Ids to the
Mouse and Rat UniProt Ids. Under ‘HT’ the page displays the number of HT experiments in which the protein was isolated by 14-3-3-
affinity capture, and under ‘contaminants’ is given the number of in-house experiments in which the protein with the input UniProt
Ids was isolated by non-specific binding to chromatography matrix with no bound 14-3-3. If the input UniProt Id belongs to a 2R-
ohnologue family, the ‘Ohnologs’ column reports the number of protein members of that family. Finally two hyperlinks connect the
page to the candidate Lynchpin site prediction (Lynchpin sites) and the detailed information page (Detailed) for the input UniProt Id.
.............................................................................................................................................................................................................................................................................................
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directly to 14-3-3, and which are indirect binding partners
for 14-3-3. To help this effort, we analysed the HT 14-3-3-
capture data sets using the filters available in ANIA. First,
we selected the seven published HT experiments (Table 1
and blue hexagons in Figure 4) that are most highly en-
riched in GD 14-3-3-binding proteins (red circles), and the
overlaps between the proteins in these HT experiments
were visualized in a VisANT graph (36) (Figure 4). We
then annotated the proteins from these HT experiments
with ANIA, where 14-3-3 binding information on these pro-
teins and other proteins in the same 2R-ohnologue families
can be found (Supplementary Tables S2 and S3).
Tailoring ANIA to analyse the human kinome
The eukaryotic protein kinase (ePK) superfamily comprises
477 protein kinases in humans (37) (Figure 5 and
Supplementary Table S2) that regulate nearly every process
in the cell. Dysregulated kinase activities are cause or
Figure 2. Advanced query results on ANIA. Example of prediction of candidate lynchpin and other 14-3-3-binding phosphosites
for the protein kinase PAK4.
.............................................................................................................................................................................................................................................................................................
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consequence in cancer and other diseases, and these
enzymes are therefore major targets for therapeutic inter-
ventions. However, regulatory interactions and feedback
mechanisms among different protein kinases mean that
kinase inhibitors often have wider effects than anticipated,
and kinase–kinase interactions can also mediate drug resist-
ance mechanisms (38).
Among the 7120 human proteins in 2419 2R-ohnologue
protein families that were assembled for ANIA, there
are 348 ePK protein kinases in 123 2R-ohnologue
families (Figures 4 and 5, and Supplementary Table S2).
Furthermore, 28 2R-ohnologues and 9 non-ohnologues of
the human kinome are known 14-3-3 binders, and these are
distributed in every major branch of the kinome tree
(Figure 5). The new paradigm of signal multiplexing by
14-3-3s might therefore help explain many of the regula-
tory interactions among protein kinases that are confound-
ing therapeutic strategies. To assist further analyses, we
therefore performed lynchpin predictions for the human
kinome, pinpointing 53 2R-ohnologue protein kinase
families with candidate lynchpins that have not been iden-
tified experimentally (Supplementary Table S4). The result
Figure 3. Example of an extended information page for the protein kinase PAK4 in ANIA. These pages include information on
somatic cancer mutations, on whether proteins appear in a data set of typical contaminants in HT experiments (from in-house
data), and enriched information from UniProt and GO.
.............................................................................................................................................................................................................................................................................................
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of this analysis can be browsed in ANIA with a hyperlinked
version of Figure 5 available at https://ania-1433.lifesci.
dundee.ac.uk/prediction/webserver/index.py/kinome.
PAK4, 6 and 7 as novel 14-3-3 binding partners
As an example, when ANIA was queried about PAK4, 6
and 7 in the type II p21-activated kinase family (UniProt
O96013, Q9NQU5 and Q9P286, respectively), both PAK4
and PAK6 have been captured by 14-3-3s in HT experiments
(Figure 1B), and PAK4 is a GD, with phosphoSer99 reported
as a 14-3-3-binding phosphosite (39). Interestingly, COSMIC
reports a Ser99Phe mutation of PAK7 in a case of malignant
melanoma, and ANIA predicts Ser99 as a candidate ‘lynch-
pin’ 14-3-3 binding phosphosite, which is conserved in
human PAK4, 6 and 7, as well as the Branchiostoma and
Ciona pro-orthologues. On PAK4, ANIA also pinpoints
Ser162, Ser181 and Ser474 for attention as candidate
14-3-3 binding sites (Figures 2 and 6, and Supplementary
Tables S2 and S3). Of these, Ser474 is in the activation loop
of the kinase domain and its phosphorylation is required
for PAK4 activity (40). Its conservation is therefore likely to
be linked to its kinase-activating role, and its position
within a functional domain does not conform to the
norm for 14-3-3-binding sites.
Experimentally, PAK4, PAK6 and PAK7 isolated from
transfected HEK293 cells could bind directly to 14-3-3,
with PAK6 and PAK7 displaying the strongest signals
(Figure 7A). The interaction of 14-3-3s with PAK4, PAK6
and PAK7 is phosphorylation dependent (Figure 7B) and
markedly enhanced for the PAK4 kinase when cells were
stimulated with PMA (Figure 7B and C). Ser162Ala and
Ser474Ala mutations had no obvious effect on 14-3-3 bind-
ing to PAK4 under any conditions tested (not shown).
However, 14-3-3 binding was decreased by Ser99Ala and
Ser181Ala mutations, with the Ser181Ala having the more
pronounced inhibitory effect (Figure 7C and D). These find-
ings indicate that phosphoSer99 (TRSN(pS99)LR) and the
less-conserved phosphoSer181 (KRPL(pS181)GP) mediate
interaction of PAK4 with a 14-3-3 dimer. For PAK6, phorbol
ester gave no enhancement of 14-3-3 binding (Figure 7C).
Of the six residues highlighted by ANIA in PAK6, mutagen-
esis indicated that Thr99 that aligns with Ser99 of PAK4 has
a minor effect on 14-3-3 binding, with a greater contribu-
tion from phosphoSer113 [RRAQ(pS113)LG] that is not con-
served in other members of this protein family (Figure 7C).
Proteome-wide prediction of 14-3-3 binding proteins
The ANIA database contains lynchpin predictions for 2963
proteins. To analyse the landscape of the most enriched
protein classes with known and predicted lynchpins, we
used the DAVID database (41). As illustrated in Figure 8,
the top three enriched protein classes identified with the
DAVID resources are kinases, and proteins containing SH3
and PH domains. Interestingly, the first cluster of known
and predicted 14-3-3-binding proteins containing phos-
phatase domains appear only at position 140 of the
DAVID ranking system (Figure 8 and Supplementary Table
S4), which may reflect that phosphatases are often regu-
lated via regulatory subunits, some of which are known
14-3-3-binding phosphoproteins. To exclude a bias towards
the protein kinases that were manually curated for the
lynchpin site predictions, we repeated the DAVID enrich-
ment analysis after filtering out the protein kinase
UniProt identifiers. Also in this case, the top enriched
classes contained SH3 and PH protein adaptor modules
(Supplementary Table S5).
Discussion
The >4000 publications on 14-3-3s listed in PubMed reflect
the pleiotropic roles of these proteins in engaging with di-
verse phosphoproteins to regulate metabolism, signal
transduction, gene expression, cytoskeletal dynamics, ves-
icle and protein trafficking, cell cycle, cell survival, growth
and proliferation. These include mammalian proteins
deregulated in diabetes, cancer and neurological disorders.
Here, we provide ANIA as a convenient pipeline for bench
scientists and clinicians to find and analyse the >2000 mam-
malian proteins that have been identified in LT and HT
14-3-3-capture experiments. ANIA stores the human
14-3-3 binding partners and maps each interaction to the
mouse and rat proteins, as these are commonly used
models for human studies. As well as providing a searchable
database for known and candidate 14-3-3-binding proteins
and phosphosites, ANIA performs sequence alignments of
2R-ohnologue families and incorporates an algorithm that
pinpoints potential 14-3-3-binding phosphosites. These pu-
tative sites provide a guide to accelerate experimental val-
idation experiments. The experimenter should also take
further criteria into account, such as the minimum distance
on a target protein that could reach from one binding
pocket to the other within the central groove of a 14-3-3
dimer (15 amino acid residues), and we therefore
Table 1. The list of HT 14-3-3 affinity capture studies in ANIA
that have the highest proportion of GD 14-3-3 binding
proteins
PMID First author Year
16959763 Angrand 2006
15778465 Benzinger 2005
19648646 Dubois 2009
17353931 Ewing 2007
22837806 Heverin 2012
15324660 Jin 2004
22251793 Nishioka 2012
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Figure 5. Mapping of known and candidate 14-3-3-binding phosphoproteins on the phylogenetic tree of the human kinome.
This image of the human kinome phylogenetic tree is useful because of its familiarity to many researchers (37), though a few
further kinases identified since 2002 are also listed in Supplementary Table S2. Protein kinases with phosphosites that conform to
candidate 14-3-3-binding sites are highlighted in green. GD 14-3-3 binders are in yellow. Stars are assigned to those GDs for
which experimentally determined 14-3-3 phosphosites were also pinpointed by ANIA as being candidate lynchpins. On a hyper-
linked version of this figure within ANIA (https://ania-1433.lifesci.dundee.ac.uk/prediction/webserver/index.py/kinome), clicking
on a kinase on the dendogram will open the relevant results overview page. Abbreviations: AGC, PKA/PKG/PKC-family kinases;
CAMK, calcium/calmodulin-dependent kinases; CK1, casein kinases; CMGC, CDK/MAPK/GSK3/CLK-family kinases; RCG, receptor
guanylate cyclases; STE, sterile homologue kinases; TK, tyrosine kinases; TKL, tyrosine kinase-like kinases; atypical protein kinases;
Other, belonging to none of the mentioned groups. The human kinome dendogram was adapted from (37).
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embedded a preliminary search for second sites in ANIA.
Special characteristics and structural information about
the target under study can also be considered. For example,
in the case of the protein kinases, ANIA highlights activa-
tion loop phosphorylations within the catalytic centres of
the enzymes for attention as potential 14-3-3-binding phos-
phosites. While perhaps premature to designate activation
loop phosphorylations as an ‘excluded group’ in ANIA,
14-3-3 binding to such sites would probably not be compat-
ible with kinase activity. Overall therefore, ANIA offers a
new tool whose value in making experiments faster and
more precise will be enhanced when experimenters draw
on specialized knowledge of their target proteins.
Here, we used ANIA to study the human kinome, and our
predictions indicate that 14-3-3s may interact with up to
40% of human kinases. This tentative figure includes the
>30 protein kinases known to bind directly to 14-3-3
(including this study), cases where known 14-3-3-binding
sites are conserved in other members of the same 2R-
ohnologue protein kinase family, and protein kinases that
display affinity for 14-3-3 in HT experiments. It would be
fascinating to have a complete map of all the protein kin-
ases that bind to 14-3-3s, their 14-3-3-binding phosphosites
and the protein kinases that phosphorylate them. Such a
connectivity diagram would provide a logical framework to
help understand complexities of kinase signaling such as
feedback mechanisms and certain unexpected pleiotropic
effects of protein kinase inhibitors. 14-3-3-binding phos-
phosites are generally created by protein kinases in the
AGC and CAMK subfamilies. AGC and CAMK enzymes are
therefore likely to be direct upstream regulators of the
many other protein kinases that are known or inferred to
be part of the 14-3-3-interactome. To understand the func-
tioning of the kinase network, we must define these regu-
latory interconnections and how they co-evolved with the
signaling network as a whole.
In common with other classes of signaling proteins, the
human protein kinome is enriched in 2R-ohnologue protein
families (1,16). Comparing the patterns of 14-3-3-binding
sites in different protein kinase 2R-ohnologues families
should therefore give insights into how the 2R-WGD expan-
sion of the protein kinome contributed to the evolution of
Figure 6. PAK4 sequence features and 14-3-3-binding sites. (A) The sequence features of PAK4 (1–591) include a p21-binding
domain (PBD) containing a Cdc42/Rac interactive binding domain (CRIB), five ‘low complexity’ regions, a guanine nucleotide
exchange factor-interaction domain (GEF-ID) and a protein kinase domain (in red). (B) The sequences around the four candidate
14-3-3-binding sites identified by ANIA (Ser99, Ser162, Ser181 and Ser474) are shown, with the relative conservation of the
sequences, comparing PAK4, PAK6 and PAK7 (which belong to the same 2R-ohnologue family) illustrated using Jalview. Note
that Ser474 in the kinase activation loop must be phosphorylated for PAK4 to be active, and was therefore provisionally rejected
as a likely lynchpin. Protein names conform to UniProt nomenclature: some authors refer to PAK6 as PAK5, while others also
refer to PAK7 as PAK5.
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Figure 7. Differential binding of 14-3-3s to overexpressed PAK4-GFP mutants. (A) HEK293 cells growing in media containing 10%
serum were transfected to express PAK4-GFP, PAK6-GFP and PAK7-GFP. GFP-tagged proteins isolated from cell lysates (20mg)
with GFP-Trap were tested for their ability to bind directly to 14-3-3s in Far-Western assays (overlay) and by co-immunopreci-
pitation of endogenous 14-3-3s (14-3-3s). Anti-GFP signals show levels of the tagged kinases in the immunoprecipitates.
(B) HEK293 cells transfected to express the GFP-tagged proteins were serum-stimulated, or serum-starved for 10h and stimulated
with PMA, as indicated. The GFP-tagged proteins bound to GFP-Trap were dephosphorylated with lambda phosphatase, or not
when the phosphatase was inhibited with EDTA. The immunoprecipitates were washed, and analysed for their ability to bind
directly to 14-3-3s (overlay), and for retention of co-purified endogenous 14-3-3 proteins (K19 pan-14-3-3 antibody). (C) After
transfection to express wild-type and mutants PAK4-GFP and PAK6-GFP proteins, HEK293 cells were serum-stimulated, or serum-
starved for 10h and stimulated with PMA, as indicated. The isolated proteins were tested for binding to 14-3-3s in a Far-Western
assay. Co-immunoprecipitating endogenous 14-3-3s were detected using the K19 pan-14-3-3 antibody. For the cell lysates,
GAPDH was loading control, and the efficacy of PMA stimulation of cells was monitored with the pERK antibody. (D) HEK293
cells were transfected to express wild-type and mutant forms of PAK4-GFP and PAK6-GFP. Proteins were immunoprecipitated
from lysates with anti-GFP and tested for 14-3-3 binding (overlay) and co-immunoprecipitation of endogenous 14-3-3 (14-3-3).
The anti-GFP antibody signals indicate total protein levels.
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the vertebrate animals. Note that closely related enzymes
are not always 2R-ohnologues of each other. For example,
Branchiostoma pro-orthologues have now been identified
for both LRRK1 and for LRKK2 in the tyrosine-kinase-like
(TLK) branch of the kinome, which suggests that both en-
zymes existed before the 2R-WGD.
While ANIA facilitates mapping of the 14-3-3-interacting
kinome, we emphasize that only the type of biochemical
analyses performed here for the PAK can define 14-3-3-
binding phosphosites with confidence. There are six PAKs
in two 2R-ohnologue families (corresponding to group I
and II PAKs), and interestingly, all six were predicted as
candidate 14-3-3-binding targets, though only PAK4 had
previously been experimentally determined as such. Here,
ANIA short-listed candidate serine and threonine residues,
which led to phosphoSer181 being experimentally identi-
fied as the major site responsible for the binding of PAK4 to
14-3-3, in addition to the previously identified
phosphoSer99 (37). Thus the ‘lynchpin’ (phosphoSer99)
need not be the site with highest 14-3-3 binding affinity.
These data are consistent with the identification of
phosphoSer181 of PAK4 in recent mass spectrometry-
based phosphoproteomic studies of proteins from melan-
oma cells (42), mouse squamous cell carcinoma (43) and
activated Natural Killer cells (44). In contrast to PAK4, the
stronger binding of PAK6 to 14-3-3 is not stimulated by
phorbol ester. The interaction with PAK6 involves Thr99,
which aligns with Ser99 of PAK4, though the much greater
contribution is from phosphoSer113. Pinpointing these sites
will facilitate studies to define how differential 14-3-3 regu-
lation of the PAK kinase family contributes to coordination
of cell morphology and other regulatory processes (40,41).
Interestingly, the analysis of proteins with candidate
lynchpin sites showed an enrichment of kinase domains,
with SH3- and PH-domain proteins ranked next. These
findings suggest that 14-3-3 proteins affect phosphoryl-
ation-based signaling networks directly at the kinases and
indirectly by modulating adaptor proteins, for example, by
14-3-3–mediated masking of the SH3 or PH domains (45,46).
Our results suggest that such mechanisms are more wide-
spread than previously identified.
In summary, ANIA provides an accessible interface to
enable anyone to (i) search experimental 14-3-3-interac-
tome data sets, and (ii) use algorithms and 2R-ohnologue
family sequence alignments to improve the prediction of
14-3-3-binding proteins and phosphosites. Combining
data on binding specificity with evolutionary perspective
should make ANIA a powerful tool for accelerating the dis-
covery of 14-3-3-based regulatory mechanisms, and learn-
ing how the whole 14-3-3-interactome works in health and
disease.
Update process
We welcome participation and feedback from the scientific
community to improve ANIA, and aim to update ANIA peri-
odically as further data become available.
Supplementary Data
Supplementary data are available at Database Online.
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Figure 8. DAVID Enrichment Analysis for GD 14-3-3 binding
proteins plus 2R-ohnologues with candidate 14-3-3-binding
lynchpin phosphosites. For the GD 14-3-3-binding proteins
plus 2R-ohnologues with candidate 14-3-3-binding lynchpins,
are given the DAVID (Database for Annotation, Visualization
and Integrated Discovery) enrichment scores relative to the
entire human proteome, for the Top 3 classes (Kinase, SH3
and PH domain containing proteins) and the score for the
first identified DAVID class containing the word phosphatase
(Phosphatase).
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